Summary of MAP PHARMACEUTICALS, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

MAPP > SEC Filings for MAPP > Form 8-K on 22-Sep-2008

All Recent SEC Filings

Show all filings for MAP PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MAP PHARMACEUTICALS, INC.

22-Sep-2008

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events

In a press release issued on September 22, 2008, MAP Pharmaceuticals, Inc. announced that it has completed patient enrollment in a Phase 3 clinical trial of its Unit Dose Budesonide product candidate in children with asthma. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No. Description

99.1 Press Release of MAP Pharmaceuticals, Inc., dated September 22, 2008

Add MAPP to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for MAPP - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.